1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
68DB4A6C6470D68F785257AEF0075CDEC
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/medical-education-technology-utilization-spending-format-types?opendocument
18
19opendocument
2034.239.153.44
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Education

Professional Medical Education Excellence: Benchmarking Critical Technology Trends and Program Characteristics in the Medical Device and Biopharmaceutical Marketplace

ID: 5237


Features:

16 Info Graphics

23 Data Graphics

250+ Metrics

9 Narratives


Pages/Slides: 46


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Professional Medical Education Excellence: Benchmarking Critical Technology Trends and Program Characteristics in the Medical Device and Biopharmaceutical Marketplace"

STUDY OVERVIEW

Professional Medical Education programs are a key way that healthcare professionals learn how to safely and effectively use new medical devices and biopharmaceutical products. While this remains as true today as it was in the past, new technologies are transforming how Medical Education groups deliver their programs to healthcare professionals.

This research study presents benchmarks and insights around Medical Education technology utilization, spending and format types that are prevalent among study participants. In addition to exploring which technologies Medical Education leaders anticipate will be used for programs in the next 2-3 years, the study presents a breakdown of which program formats or venues are most popular. Medical Education executives and managers can use this study to compare their use of technology with other organizations.

The study in this report are presented in two segments: Medical Device and Pharmaceutical.

KEY TOPICS

  • Technology Benchmarks & Trends
  • Medical Education Program Benchmarks  

SAMPLE KEY METRICS
  • Anticipated percent increase of technology-based education programs in next 2-3 years
  • Anticipated percentage of education budget invested in education delivered through new technologies in next 2-3 years
  • The percentage of technology-delivered programs allocated to various new technologies in the next 2-3 years
  • Will funding for various technology-based delivery forms rise, fall or stay the same in next 2-3 years
  • Breakdown of formats or venues used for the delivery of medical education programs
  • Programs most effective in supporting improved patient outcomes
  • In next 2-3 years will programs in Latin America, Asia, emerging markets expand or shrink
SAMPLE KEY FINDING

  • New Technologies Growth: Pharma companies see technology-based programs growing in double-digits, much faster than do medical device peers. Two thirds of the Pharma segment see tech-based education programs growing above 10% in high double-digits for the next three years. Pharma sees much higher growth here than do device companies in which two-thirds of companies expect no change or single-digit growth.
  • New Technologies Investment: Both pharma & medical device companies – on average -- will invest 1/3 of future education budgets in programs delivered through new technologies. Some companies target spending up to 60-80% of their MedEd budgets in these new delivery technologies.
METHODOLOGY

Best Practices, LLC engaged 32 Medical Education leaders at 31 companies through a benchmarking survey instrument. In addition, research analysts conducted deep-dive executive interviews with 5 selected respondents to collect qualitative data and insights. Fourteen participants represent the Medical Device Segment and 18 participants represent the Pharma Segment.

Industries Profiled:
Consumer Products; Diagnostic; Pharmaceutical; Medical Device; Health Care; Technology; Orthopaedics; Biotech; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Bayer Healthcare; Becton Dickinson; Boston Scientific; Covidien; Bard; Ethicon Endo Surgery; Medrad; Medtronic; Orthofix; Philips; Smith and Nephew; Terumo; Zimmer; Amylin; Astellas Pharma; AstraZeneca; Baxter; Boehringer Ingelheim; Novartis; Sanofi; UCB; Gilead; Esteve; Grunenthal; Insight Pharmaceuticals; Johnson & Johnson; Regeneron; Stallergenes; Xanodyne

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.